Evidence map›Paper›PMID 27678172›Full record

ArticleScientific reports2016

Illa Tea, Estelle Martineau, Ingrid Antheaume, Julie Lalande, Caroline Mauve, Francoise Gilard, Sophie Barillé-Nion, Anneke C Blackburn, Guillaume Tcherkez

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Nitrogen Isotope Effects in Urea Metabolism: From Biochemistry toInternational journal of molecular sciences · 2026
    Review
  5. Alterations inCancers · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cancers · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Position-specificRapid communications in mass spectrometry : RCM · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Illa TeaEBSI team, CEISAM, University of Nantes-CNRS UMR 6230, 2 rue de la Houssinière BP 92208, F-44322 Nantes, France.
Estelle MartineauEBSI team, CEISAM, University of Nantes-CNRS UMR 6230, 2 rue de la Houssinière BP 92208, F-44322 Nantes, France.
Ingrid AntheaumeEBSI team, CEISAM, University of Nantes-CNRS UMR 6230, 2 rue de la Houssinière BP 92208, F-44322 Nantes, France.
Julie LalandeEBSI team, CEISAM, University of Nantes-CNRS UMR 6230, 2 rue de la Houssinière BP 92208, F-44322 Nantes, France.
Caroline MauvePlateforme Métabolisme-Métabolome, Bâtiment 630 IPS2, Université Paris-Sud, 91405 Orsay cedex, France.
Francoise GilardPlateforme Métabolisme-Métabolome, Bâtiment 630 IPS2, Université Paris-Sud, 91405 Orsay cedex, France.
Sophie Barillé-NionCRCNA, UMR INSERM U892/CNRS 6299/Université de Nantes, Team 8 «Cell survival and tumor escape in breast cancers», Institut de Recherche en Santé de l'Université de Nantes, 8 quai Moncousu, BP 70721, 44 007 Nantes cedex 1, France.
Anneke C BlackburnCancer Metabolism and Genetics Group, The John Curtin School of Medical Research, The Australian National University, Canberra 2601 ACT, Australia.
Guillaume TcherkezResearch School of Biology, The Australian National University, Canberra 2601 ACT, Australia.
Australian National University · AUChimie et Interdisciplinarité, Synthèse, Analyse, Modélisation · FRUniversité Paris-Sud · FRCentre National de la Recherche Scientifique · FRInserm · FRNantes Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is the most common cancer in women worldwide. Despite the information provided by anatomopathological assessment and molecular markers (such as receptor expression ER, PR, HER2), breast cancer therapies and prognostics depend on the metabolic properties of tumor cells. However, metabolomics have not provided a robust and congruent biomarker yet, likely because individual metabolite contents are insufficient to encapsulate all of the alterations in metabolic fluxes. Here, we took advantage of natural

Identifiers

PMID27678172
PMCPMC5039687
OpenAlexW2524154889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.